Wells Fargo analyst Stephen Baxter raised the firm’s price target on Humana (HUM) to $315 from $290 and keeps an Overweight rating on the ...

Wells Fargo analyst Steve Baxter maintained a Buy rating on Humana (HUM – Research Report) today and set a price target of $315.00. The ...

Clover Health’s 32% dip following its Q3 earnings could be an opportunity to accumulate shares. Find out why I’m reiterating ...

Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” third-quarter 2024 investor letter. A ...

Medicare-focused insurers like Humana and CVS could benefit.

Stocks of companies more focused on the U.S. economy were also rising more than the rest of the market, including a 1.5% ...

U.S. stocks rose Monday, led by those seen as benefiting the most from Donald Trump's reelection as president, but drops for ...

Asian shares are trading lower, despite a rally on Wall Street in stocks seen as benefiting the most from Donald Trump’s reelection as U.S. president ...

U.S. stocks rose Monday, led by those seen as benefiting the most from Donald Trump’s reelection as president, but drops for ...